CNC CENTENE CORP

NYSE Hospital & Medical Service Plans DE CIK: 0001071739
AI RATING
HOLD
55% Confidence

Investment Thesis

Centene demonstrates strong top-line growth (11.6% YoY) and robust cash generation ($4.2B FCF), supported by a solid balance sheet with $21.3B cash and manageable 0.76x debt/equity. However, the company faces significant operational headwinds: net income is flat despite double-digit revenue growth, and diluted EPS declined 314% YoY, indicating margin compression and potential share dilution that offset otherwise healthy fundamentals.

Strengths

  • + Strong revenue growth of 11.6% YoY in large $49.9B base
  • + Excellent cash generation with $4.2B free cash flow (8.3% FCF margin) and $21.3B cash position
  • + Solid balance sheet with manageable debt/equity of 0.76x and strong interest coverage of 10.5x
  • + Low capital intensity ($200M CapEx) characteristic of insurance business model

Risks

  • ! Severe profitability deceleration: net income flat despite 11.6% revenue growth indicates margin compression
  • ! Alarming 314% diluted EPS decline YoY suggests substantial share dilution or operational deterioration
  • ! Thin profitability margins (3.1% net margin, 3.7% operating margin) leave minimal buffer for sector headwinds
  • ! Weak returns metrics: 7.2% ROE and 1.9% ROA indicate inefficient capital deployment
  • ! Tight liquidity with current ratio of only 1.12x

Key Metrics to Watch

Financial Metrics

Revenue
49.9B
Net Income
1.5B
EPS (Diluted)
$3.11
Free Cash Flow
4.2B
Total Assets
81.2B
Cash
21.3B

Profitability Ratios

Gross Margin 11.3%
Operating Margin 3.7%
Net Margin 3.1%
ROE 7.2%
ROA 1.9%
FCF Margin 8.3%

Balance Sheet & Liquidity

Current Ratio
1.12x
Quick Ratio
1.12x
Debt/Equity
0.76x
Debt/Assets
73.5%
Interest Coverage
10.46x
Long-term Debt
16.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-06T12:54:46.946091 | Data as of: 2026-03-31 | Powered by Claude AI